A review of bioactive materials and chronic wounds.
An increasing number of bioactive materials are indicated for the treatment of chronic lower extremity ulcers. They are promising adjuncts to standard therapy. When used in conjunction with standard therapy for venous leg ulcers and diabetic foot ulcers, bioactive materials may increase the likelihood and rate of healing. This review compares commonly available bioactive materials indicated for chronic wound healing and provides an overview of the relevant Current Procedural Terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) codes for these products.
Plotner
Alisha N
AN
Northeastern Ohio Universities College of Medicine, Rootstown, USA.
Mostow
Eliot N
EN
D002908:Chronic Disease; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use; D003094:Collagen / Q000627:therapeutic use; D039702:Current Procedural Terminology; D006801:Humans; D007871:Leg Ulcer / Q000628:therapy*; D017768:Skin, Artificial; D023822:Tissue Engineering
C117898:Apligraf; D020099:Coated Materials, Biocompatible; C512800:TransCyte; D003094:Collagen